Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial.
The impact on carriage and optimal schedule for primary vaccination of older children with 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) are unknown.600 Kenyan children aged 12-59 months were vaccinated at days 0, 60 and 180 in a double-blind random...
Main Authors: | Laura L Hammitt, John Ojal, Mahfudh Bashraheil, Susan C Morpeth, Angela Karani, Ahsan Habib, Dorota Borys, David Goldblatt, J Anthony G Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3897448?pdf=render |
Similar Items
-
Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers.
by: Leah M Feazel, et al.
Published: (2015-01-01) -
Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies
by: Dr. Laura L Hammitt, MD, et al.
Published: (2014-07-01) -
Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan
by: Chun-Yi Lu, et al.
Published: (2020-08-01) -
Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan
by: Tzou-Yien Lin, et al.
Published: (2012-09-01) -
Correction to: Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan
by: Chun-Yi Lu, et al.
Published: (2021-05-01)